Search Results
Sep 03, 2025, 08:45 ET Alejandro Przygoda lanza Przygoda & Co., una firma global de banca de inversión independiente
trabajó durante 18 años en Credit Suisse, desempeñándose los últimos 10 como director global de FIG. Przygoda comenzó su carrera en banca de inversión en CS First Boston, Nueva York, en 1995 y ocupó altos cargos en Greenhill y UBS. Fue Gerente Financiero de la filial argentina
More news about: Przygoda & Co. LLC
Sep 03, 2025, 08:45 ET Alejandro Przygoda Launches Przygoda & Co., a Global Independent Investment Banking Firm
Previously, he spent 18 years at Credit Suisse, serving the last 10 as the Global Head of FIG. Mr. Przygoda started his investment banking career at CS First Boston in New York in 1995 and held senior roles at Greenhill and UBS. He was the Chief Financial Officer of General
More news about: Przygoda & Co. LLC
Sep 03, 2025, 08:45 ET Alejandro Przygoda lança a Przygoda & Co., uma empresa global de banco de investimento independente
ele passou 18 anos no Credit Suisse, servindo os últimos 10 como chefe global da FIG. O Sr. Przygoda iniciou sua carreira de banco de investimento na CS First Boston em Nova York em 1995 e ocupou cargos seniores na Greenhill e na UBS. Foi Diretor Financeiro da subsidiária
More news about: Przygoda & Co. LLC
Sep 03, 2025, 08:45 ET Alejandro Przygoda lance Przygoda & Co., une banque d'investissement mondiale indépendante
Credit Suisse, dont les 10 dernières années en tant que responsable mondial de la FIG. M. Przygoda a commencé sa carrière de banquier d'affaires chez CS First Boston à New York en 1995 et a occupé des postes de direction chez Greenhill et UBS. Il a été directeur financier
More news about: Przygoda & Co. LLC
Sep 03, 2025, 08:01 ET LiftForward Technology Supporting Officeworks Upgrade+ in Australia
in-store rollout follows a successful online launch. *Officeworks Upgrade+ is available on participating Latitude credit cards. Latitude T&Cs, monthly credit card fee will apply. Other credit card fees and charges may apply. See Officeworks
More news about: LiftForward, Inc.
Sep 03, 2025, 08:01 ET LiftForward Technology Supporting Officeworks Upgrade+ in Australia
in-store rollout follows a successful online launch. *Officeworks Upgrade+ is available on participating Latitude credit cards. Latitude T&Cs, monthly credit card fee will apply. Other credit card fees and charges may apply. See Officeworks
More news about: LiftForward, Inc.
Sep 03, 2025, 07:00 ET Capital Square Acquires Fort Worth Ground Lease for New High Leverage DST Investment
The unsubordinated ground lease, which has 95 years remaining on its term, was acquired on behalf of CS1031 Zero Coupon DFW Hospitality, DST, a Delaware statutory trust (DST) investment offering. The offering seeks to raise
More news about: Capital Square
Sep 03, 2025, 06:00 ET Quad-C Management Announces Investment in Accurate Meter & Supply
management to expand its geographic footprint, broaden its service offerings and capitalize on industry tailwinds." The Accurate partnership is Quad-C's latest investment in the specialty distribution sector. Other current and past investments include Legacy Food Group, SEI Group, Krayden, Stanton
More news about: Quad-C Management, Inc.
Sep 02, 2025, 11:00 ET Bastion Fiduciary Marks 12th Anniversary of Actively Managed International Portfolios
https://lastbastion.com/abroadabroad. About Bastion FiduciaryBastion Fiduciary is a fee-only, SEC-registered investment advisor built on the three Cs: Culture, Community, and Character. We are a fiduciary financial firm founded by veteran military officers committed to disciplined processes, personal
More news about: Bastion Fiduciary
Sep 02, 2025, 04:57 ET ICFAI Business School Equips Students with Bloomberg, SAP Labs
supply chain management (SD, MM, PP) and finance (FI, CO) to human resources (HCM), project systems (PS), asset management (EAM), and customer service (CS, QM), they understand how different business functions are integrated through ERP systems. This is further reinforced with case studies that replicate
More news about: ICFAI Business School (IBS)
Sep 02, 2025, 04:00 ET AI splňuje náročnou spolehlivost: Getac rozšiřuje svou řadu univerzálních odolných zařízení v terénu uvedením nového tabletu F120 a notebooku V120 připravených pro AI
multimedia:https://www.prnewswire.com/cs/tiskova-zprava/ai-spluje-naronou-spolehlivost-getac-roziuje-svou-adu-univerzalnich-odolnych-zaizeni-v-terenu-uvedenim-noveho-tabletu-f120-a-notebooku-v120-pipravenych-pro-ai-302540855.html
More news about: Getac Technology Corporation
Sep 02, 2025, 03:00 ET CS Analytical & Gas Testing Analytical Hosting Educational Webinar on USP/EP Gas Qualification Testing
About CS Analytical Laboratory The world's only cGMP, FDA-registered contract laboratory exclusively designed and dedicated to container testing for the pharmaceutical, biotechnology, and medical device industries, the CS Analytical Team includes world-leading
More news about: CS Analytical
Sep 01, 2025, 05:21 ET Sungrow avanza con nuevas soluciones de energía solar y de almacenamiento en la Intersolar South America 2025
precedentes en Chile.Sector comercial e industrial: el sistema de almacenamiento de energía PowerStack 255CS con refrigeración líquida, construido con avanzadas celdas de batería de 314 Ah, ofrece opciones de capacidad flexibles de 257 kWh (2 horas) o 514
More news about: Sungrow Power Supply Co., Ltd.
Aug 31, 2025, 12:15 ET New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump
attack, each year2 and the overall incidence rate of cardiogenic shock in patients with STEMI is up to 10%3. Cardiogenic shock (CS) is the leading cause of in-hospital mortality in patients with STEMI4. Impella, the world's smallest heart pump, is inserted into
More news about: Johnson & Johnson MedTech
Aug 29, 2025, 16:15 ET Patriot Files NI 43-101 Technical Report on the Shaakichiuwaanaan Mineral Resource Estimate, Quebec, Canada
4.40% Cs2O, Indicated, and 1.70 Mt at 2.40% Cs2O, Inferred. Additionally, the Project hosts a Consolidated Mineral Resource, which includes the Rigel and Vega caesium zones, totalling 108.0 Mt at 1.40% Li2O, 0.11% Cs2O, 166 ppm
More news about: Patriot Battery Metals Inc.
Aug 29, 2025, 07:50 ET Tratamiento clínico de edición de bases de alta precisión para la anemia de células falciformes
eliminando así la necesidad de un donante y ofreciendo un tratamiento más corto y potencialmente más seguro. CS-101: Edición de bases de precisión para hemoglobinopatías CS-101 es una terapia de edición génica basada en la plataforma de transformer Base Editor (tBE) (Wang et al,
More news about: CorrectSequence Therapeutics
Aug 29, 2025, 03:00 ET CoinShares Announces Q2 2025 Results
Aug. 29, 2025 /PRNewswire/ -- CoinShares International Limited ("CoinShares'' or "the Group") (Nasdaq Stockholm: CS; US OTCQX: CNSRF), the leading European asset manager specialising in digital assets, has today published its results for the quarter ending 30th
More news about: CoinShares Group
Aug 29, 2025, 02:00 ET Traitement clinique de la drépanocytose par édition de base de haute précision -- le CS-101 de CorrectSequence Therapeutics obtient des résultats prometteurs chez la première patiente
besoin d'un donneur et offre une voie de traitement plus courte et potentiellement plus sûre. Le CS-101 : l'édition de base de précision pour les hémoglobinopathies Le CS-101 est une thérapie d'édition génique basée sur la plateforme transformer Base Editor (tBE) de haute précision
More news about: CorrectSequence Therapeutics
Aug 29, 2025, 00:16 ET Sungrow Powers Ahead with New Solar and Storage Solutions at Intersolar South America 2025
1 GWh contract with Zelestra for a landmark project in Chile.C&I: The PowerStack 255CS liquid-cooled ESS, built with advanced 314 Ah battery cells, offers flexible capacity options of 257 kWh (2-hour) or 514 kWh (4-hour), >90% round-trip
More news about: Sungrow Power Supply Co., Ltd.
Aug 28, 2025, 05:06 ET Trattamento clinico di base editing ad alta precisione per l'anemia falciforme: CS-101 di CorrectSequence Therapeutics ottiene risultati promettenti sul primo paziente
eliminando la necessità di un donatore e offrendo un percorso terapeutico più breve e potenzialmente più sicuro. CS-101: base editing di precisione per le emoglobinopatie CS-101 è una terapia di editing genetico basata sulla piattaforma tBE (transformer Base Editor) ad alta precisione (Wang
More news about: CorrectSequence Therapeutics
Aug 28, 2025, 04:49 ET Hochpräzise Basen-Editierung zur klinischen Behandlung der Sichelzellenkrankheit - CS-101 von CorrectSequence Therapeutics erzielt vielversprechende Ergebnisse bei erstem Patienten
Spender mehr benötigt wird und eine kürzere, potenziell sicherere Behandlung möglich ist. CS-101: Präzisions-Basen-Editierung für Hämoglobinopathien CS-101 ist eine Gen-Editierungstherapie, die auf der hochpräzisen transformer Base Editor (tBE)-Plattform
More news about: CorrectSequence Therapeutics
Aug 27, 2025, 07:30 ET Over 1,000 High School Students Nationwide Awarded for Top Performance in College Courses from Top Universities
Principal MunnellyMastery CHS-Lenfest CampusMastery CHS-Lenfest Campus, Principal ZiembaMastery CS-Hardy WilliamsMastery Charter Schools-Hardy Williams, Principal MeltzerPhiladelphia
More news about: The National Education Equity Lab
Aug 26, 2025, 10:00 ET High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient
cells — eliminating the need for a donor and offering a shorter, potentially safer treatment path. CS-101: Precision Base Editing for HemoglobinopathiesCS-101 is a gene-editing therapy based on the high-precision transformer Base Editor (tBE) platform (Wang et al.,
More news about: CorrectSequence Therapeutics
Aug 26, 2025, 08:49 ET Ping An Reports Stable Growth in Operating Profit Attributable to Shareholders of the Parent Company in 1H2025; Life & Health NBV Surges 39.8% YoY Interim Dividend Increases to RMB0.95 Per Share
opening in July. Ping An P&C maintained steady revenue growth with improved business quality. In the first half of 2025, Ping An P&C's premium income rose by 7.1% YoY to RMB171,857 million, and insurance revenue rose by 2.3% YoY to RMB165,661
More news about: Ping An Insurance (Group) Company of China, Ltd.
Aug 26, 2025, 08:33 ET Ping An Reports Stable Growth in Operating Profit Attributable to Shareholders of the Parent Company in 1H2025; Life & Health NBV Surges 39.8% YoY Interim Dividend Increases to RMB0.95 Per Share
opening in July. Ping An P&C maintained steady revenue growth with improved business quality. In the first half of 2025, Ping An P&C's premium income rose by 7.1% YoY to RMB171,857 million, and insurance revenue rose by 2.3% YoY to RMB165,661
More news about: Ping An Insurance (Group) Company of China, Ltd.